Boston Scientific Corp. (BSX)
42.30
+0.26
(+0.62%)
USD |
NYSE |
Oct 09, 14:25
Boston Scientific Enterprise Value : 73.04B for Oct. 8, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 08, 2026 | 73.04B |
| October 07, 2026 | 72.37B |
| October 06, 2026 | 73.25B |
| October 05, 2026 | 73.56B |
| October 02, 2026 | 73.85B |
| October 01, 2026 | 74.76B |
| September 30, 2026 | 75.37B |
| September 29, 2026 | 75.70B |
| September 28, 2026 | 76.03B |
| September 25, 2026 | 75.76B |
| September 24, 2026 | 76.86B |
| September 23, 2026 | 76.77B |
| September 22, 2026 | 77.20B |
| September 21, 2026 | 75.47B |
| September 18, 2026 | 74.92B |
| September 17, 2026 | 75.22B |
| September 16, 2026 | 75.74B |
| September 15, 2026 | 75.68B |
| September 14, 2026 | 77.39B |
| September 11, 2026 | 74.40B |
| September 10, 2026 | 74.57B |
| September 09, 2026 | 77.26B |
| September 08, 2026 | 77.29B |
| September 04, 2026 | 81.37B |
| September 03, 2026 | 80.14B |
| Date | Value |
|---|---|
| September 02, 2026 | 82.20B |
| September 01, 2026 | 81.78B |
| August 31, 2026 | 82.09B |
| August 28, 2026 | 79.98B |
| August 27, 2026 | 79.74B |
| August 26, 2026 | 81.91B |
| August 25, 2026 | 84.35B |
| August 24, 2026 | 83.12B |
| August 21, 2026 | 85.09B |
| August 20, 2026 | 83.64B |
| August 19, 2026 | 87.46B |
| August 18, 2026 | 85.23B |
| August 17, 2026 | 86.62B |
| August 14, 2026 | 87.20B |
| August 13, 2026 | 87.00B |
| August 12, 2026 | 86.61B |
| August 11, 2026 | 86.27B |
| August 10, 2026 | 85.22B |
| August 07, 2026 | 83.56B |
| August 06, 2026 | 83.54B |
| August 05, 2026 | 81.28B |
| August 04, 2026 | 83.24B |
| August 03, 2026 | 82.28B |
| July 31, 2026 | 79.82B |
| July 30, 2026 | 78.77B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 198.08B |
| Becton, Dickinson & Co. | 65.72B |
| Intuitive Surgical, Inc. | 141.90B |
| Stryker Corp. | 118.21B |
| Johnson & Johnson | 645.94B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 905.00M |
| Revenue (Quarterly) | 5.442B |
| Total Expenses (Quarterly) | 4.535B |
| EPS Diluted (Quarterly) | 0.615 |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 16.63% |
| Earnings Yield | 5.83% |
| Operating Earnings Yield | 7.26% |
| Normalized Earnings Yield | 6.102 |